PARIS, France, December 11th, 2019 – Mobidiag Ltd., a molecular diagnostics company with complementary platforms that address antimicrobial resistance and other areas of unmet diagnostic need, will host a symposium at the 39th Interdisciplinary Meeting of Anti-Infectious Chemotherapy (RICAI) conference in Paris, from the 16th to 17th of December.
The RICAI conference is an annual meeting bringing together leading French clinicians and microbiologists (parasitologists, virologists, bacteriologists) and innovative commercial companies in diagnostics.
Mobidiag will hold a symposium on December 16th from 12h45 to 13h45, in spoken French. The symposium will showcase the Company’s automated molecular diagnostics solutions, Amplidiag® and Novodiag®, and their state-of-the-art capabilities in the rapid identification of infectious diseases and antimicrobial drug resistance. At the event, a number of leading clinicians will present data and share their experience of using Mobidiag’s solutions.
The presentations will feature customer experiences of the Amplidiag® Stool Parasites test, and also initial feedback of the recently launched Novodiag® Stool Parasites test. The Amplidiag® H. pylori+ClariR and Novodiag® Bacterial GE tests, both currently in routine use in healthcare settings, will also be discussed at the symposium.
Confirmed speakers at the Mobidiag symposium include:
• Pamela Chauvin, Biologist, CHU Toulouse
• Frédéric Heluwaert, Doctor, Hepatic-Gastroenterology and Digestive Endoscopy department, CH Annecy
• Philippe Lehours, University Professor and Pharmacist, Director of the National Reference Center for Campylobacters and Helicobacters, CNR Bordeaux
Following the presentations, a demonstration of both Amplidiag® and Novodiag® solutions will be made at booth No.13, showcasing how Mobidiag can support the everyday work of healthcare practitioners.
Yann Marcy, President at Mobidiag France, commented: “Faced with the major global health challenge of accelerating antibiotic resistance, Mobidiag is developing innovative, simple and fast solutions. Once again, we are pleased to organize this symposium at RICAI, which will allow our customers to share their experiences of our Amplidiag® and Novodiag® solutions being used in routine practice.”
A white paper will be made available following the event.
Register to the symposium here
Johanna Sarapää, Marketing Communications
+358 10 2054 771
Consilium Strategic Communications
Chris Gardner, Matthew Neal, Chris Welsh
T: +44 (0)203 709 5700
Access full press release in French